Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0QNA stock hub

LON/0QNA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0QNAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

632.3M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0QNA

In the news

Latest news · LON/0QNA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E12.1

P25 12.9P50 16.9P75 23.5

Trailing P/E16.8

P25 15.9P50 22.9P75 35.8

ROE38.5

P25 -54.2P50 2.1P75 13.7

ROIC79.9

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0QNA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

214

Groups with data

Currency

CHF

Showing 214 of 214 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Switzerland
Country code	UK
Employees	189
Employees Change	16%
Employees Change Percent	9.76
Enterprise value	CHF 565.7M
Exchange	London Stock Exchange
Financial currency	CHF
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	CH0011432447
Last refreshed	2026-05-10
Market cap	CHF 632.3M
Price	CHF 54.32
Price currency	CHF
Rev Per Employee	1,152,072.88x
Sector	Healthcare
Sic	2836
Symbol	lon/0QNA
Website	https://www.basilea.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.96%
EV Earnings	15x
EV/EBIT	11.47x
EV/EBITDA	10.65x
EV/FCF	10.15x
EV/Sales	2.58x
FCF yield	8.81%
Forward P/E	12.08x
P/B ratio	5.27x
P/E ratio	16.77x
P/S ratio	2.9x
PE Ratio10 Y	63.74x
PE Ratio3 Y	10.55x
PE Ratio5 Y	23.41x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	22.48%
EBITDA Margin	23.26%
FCF margin	25.59%
Gross margin	37.51%
Gross Profit	CHF 81.7M
Gross Profit Growth	-20.46%
Gross Profit Growth Q	-32.9%
Gross Profit Growth3 Y	53.45%
Gross Profit Growth5 Y	-2.16%
Net Income	CHF 37.7M
Net Income Growth	-48.14%
Net Income Growth Q	-57.02%
Net Income Growth Years	0%
Net Income Growth5 Y	-6.46%
Pretax Margin	19.74%
Profit Margin	17.32%
Profit Per Employee	CHF 199,498
Profitable Years	4
ROA	12.1
Roa5y	8.66
ROCE	22.45
ROE	38.52
ROIC	79.9

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-3.88%
Cagr1y	21.26%
Cagr3y	5.72%
Cagr5y	4.33%
EPS Growth	-46.05
EPS Growth Q	-55.15
EPS Growth Years	0
EPS Growth5 Y	-6.79
FCF Growth	-18.15%
FCF Growth Q	-33.45%
FCF Growth3 Y	85.38%
FCF Growth5 Y	17.16%
OCF Growth	-16.5%
OCF Growth Q	-30.84%
OCF Growth3 Y	81.99%
OCF Growth5 Y	16.63%
Revenue Growth	11.43x
Revenue Growth Q	-2.9x
Revenue Growth Years	3x
Revenue Growth3 Y	15.96x
Revenue Growth5 Y	5.83x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CHF 0.86
Assets	CHF 264.2M
Cash	CHF 149.7M
Current Assets	CHF 237.7M
Current Liabilities	CHF 46.5M
Debt	CHF 83.6M
Debt EBITDA	CHF 1.59
Debt Equity	CHF 0.7
Debt FCF	CHF 1.5
Equity	CHF 119.9M
Interest Coverage	15.56
Liabilities	CHF 144.4M
Long Term Assets	CHF 26.6M
Long Term Liabilities	CHF 97.9M
Net Cash	CHF 66.1M
Net Cash By Market Cap	CHF 10.46
Net Cash Growth	680.74%
Net Debt EBITDA	CHF -1.31
Net Debt Equity	CHF -0.55
Net Debt FCF	CHF -1.19
Tangible Book Value	CHF 119.5M
Tangible Book Value Per Share	CHF 9.72
WACC	6.2

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.11
Inventory Turnover	5.46
Net Working Capital	CHF 42M
Quick ratio	4.53
Working Capital	CHF 189.8M
Working Capital Turnover	CHF 1.15

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.23%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-32.69%
1Y total return	21.25%
200-day SMA	51.55
3Y total return	18.15%
50-day SMA	53.73
50-day SMA vs 200-day SMA	50over200
5Y total return	23.62%
All Time High	126
All Time High Change	-56.89%
All Time High Date	2015-06-04
All Time Low	29.5
All Time Low Change	84.13%
All Time Low Date	2020-03-16
ATR	1.16
Beta	0.41
Ch YTD	-1.1
High	54.9
High52	59.55
High52 Date	2025-07-29
High52ch	-8.79%
Low	53.9
Low52	43.2
Low52 Date	2025-05-14
Low52ch	25.74%
Ma50ch	1.1%
Price vs 200-day SMA	5.37%
RSI	50.24
RSI Monthly	58.92
RSI Weekly	54.24
Sharpe ratio	0.69x
Sortino ratio	1.32
Total Return	1.23%
Tr YTD	-1.1
Tr1m	0.72%
Tr1w	-1.01%
Tr3m	-4.04%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CHF 49M
Operating Income Growth	-31.76
Operating Income Growth Q	-46.6
Operating Income Growth5 Y	-5.1
Operating margin	22.48

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	12,207,789%
Shares Insiders	0.68%
Shares Institutions	34.46%
Shares Qo Q	-2.36%
Shares Yo Y	-1.23%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CHF 50.8M
Average Volume	4,927.65x
Bv Per Share	9.75
CAPEX	CHF -2.5M
Ch10y	-32.69
Ch1m	0.72
Ch1w	-1.01
Ch1y	21.25
Ch3m	-4.04
Ch3y	18.15
Ch5y	23.62
Ch6m	21.52
Change	-0.33%
Change From Open	0.68
Close	54.5
Days Gap	-1.01
Depreciation Amortization	1,712,575.9
Dollar Volume	197,284.6
Earnings Date	2026-08-18
EBIT	CHF 49M
EBITDA	CHF 50.7M
EPS	CHF 2.94
F Score	5
FCF	CHF 55.7M
FCF EV Yield	9.85x
Financing CF	-20,075,383
Fiscal Year End	December
Founded	2,000
Graham Number	27.39703
Graham Upside	-49.56
Income Tax	CHF 5.3M
Investing CF	-2,681,715
Is Primary Listing	0
Last Earnings Date	2026-02-17
Last Report Date	2025-12-31
Lynch Fair Value	CHF 16.2
Lynch Upside	-70.18
Ma150	52.17
Ma150ch	4.12%
Ma20	54.78
Ma20ch	-0.84%
Net CF	35,397,328
Next Earnings Date	2026-08-18
Open	53.95
P FCF Ratio	11.35
P OCF Ratio	10.87
Position In Range	41.85
Ppne	17,135,199.7
Price Date	2026-05-08
Price EBITDA	CHF 12.48
Ptbv Ratio	5.29
Relative Volume	0.74x
Revenue	217,741,774x
SBC By Revenue	2.25x
Share Based Comp	4,908,045
Tax By Revenue	2.42x
Tax Rate	12.28%
Tr6m	21.52%
Volume	3,632
Z Score	0.15

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0QNA pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0QNA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0QNA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+34.5%

Share of float held by funds and institutions

Insider ownership

+0.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-1.2%

Negative means the company is buying back shares.

Technical

LON/0QNA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

50.2

Neutral momentum band

Price vs 200-day MA

+5.4%

50/200-day relationship not available

Beta (5Y)

0.41

Less volatile than the market

Sharpe ratio

0.69

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0QNA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0QNA stock rating?

lon/0QNA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0QNA analysis?

The full report lives at /stocks/lon/0QNA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0QNA?

The latest report frames lon/0QNA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0QNA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.